openPR Logo
Press release

Radiopharmaceuticals Market Size And Industry Forecast By 2030

11-17-2023 07:12 AM CET | IT, New Media & Software

Press release from: DataM Intelligence 4Market Research

Radiopharmaceutical Market - DataM Intelligence

Radiopharmaceutical Market - DataM Intelligence

Radiopharmaceuticals Market Poised for Strong Growth with a CAGR of 6.2% Forecasted from 2023 to 2030:

The Radiopharmaceuticals Market is set to witness robust growth at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2023 to 2030. Market trends indicate an increasing demand for radiopharmaceuticals in the diagnosis and treatment of various diseases, with North America experiencing a surge in demand from hospitals and diagnostic imaging centers.

The market, valued at USD 6,242.80 million in 2021, is anticipated to see substantial expansion driven by factors such as the prevalence of diseases like cancer and neurological disorders, a growing geriatric population, and extensive research and development activities in the field.

Radiopharmaceuticals, containing radioactive substances utilized for diagnosing and treating diseases, particularly in oncology and cardiology, have become pivotal in the medical landscape. The market's upward trajectory is further fueled by ongoing product developments in the radiopharmaceutical sector.

Download Sample: https://www.datamintelligence.com/download-sample/radiopharmaceuticals-market

Market Trends and Dynamics:
The increasing prevalence of diseases, coupled with the rising adoption of radiopharmaceuticals for diagnosis and treatment, forms the crux of the market's growth. Notably, the development of radiopharmaceutical therapy for various cancers, including lung, melanoma, colorectal, and leukemia, showcases a promising avenue for market expansion.

Furthermore, researchers are exploring innovative combinations of radiopharmaceuticals with radiation sensitizers to enhance their efficacy. Clinical trials, such as lutetium Lu 177-dotatate combined with the radiation sensitizer triapine, signify advancements in cancer treatment modalities.

Challenges and Growth Restraints:
Despite the promising outlook, the radiopharmaceuticals market faces challenges. The therapy's disadvantages, including radiation risks, non-disease-specific images, the requirement for bloodstream injections, radioactive waste disposal, and high treatment costs, present hurdles to market growth.

Segmentation Analysis:
The oncology segment is projected to experience the fastest CAGR during the forecast period (2023-2030). A surge in worldwide cancer cases, predicted to increase by 60% from 2018 to 2040, accentuates the critical role of radiopharmaceutical therapy in cancer treatment. Key players, such as Bayer, Novartis, and Telix Pharma, are actively developing innovative agents for various cancers, contributing to the segment's growth.

Geographical Share:
North America holds the largest market share, driven by an increasing incidence of cancer and other diseases, advanced healthcare infrastructure, new product launches, and the presence of key market players. Initiatives such as Fusion Pharmaceuticals' collaboration with AstraZeneca and PETNET Solutions Inc.'s expansion in Florida further reinforce North America's dominance in the global radiopharmaceuticals market.

Competitive Landscape:
The radiopharmaceuticals market features a moderately competitive landscape, with global leaders such as Siemens AG, Positron Corporation, Curium, GE Healthcare, Lantheus Holdings Inc., Sotera Health LLC, Bayer AG, Eckert & Ziegler, Novartis AG, and BWX Technologies Inc. adopting growth strategies like product launches, acquisitions, and collaborations.

Conclusion:
As the global radiopharmaceuticals market continues its upward trajectory, driven by technological advancements and increasing demand for innovative cancer treatments, key players are positioned to lead through strategic initiatives. The forecasted CAGR of 6.2% from 2023 to 2030 underscores the market's resilience and potential for significant expansion.

Related Report:

Biopharmaceutical Tubing Market: https://www.datamintelligence.com/research-report/biopharmaceutical-tubing-market

Biopharmaceuticals Market: https://www.datamintelligence.com/research-report/biopharmaceuticals-market

Single-Use Bioprocessing Market: https://www.datamintelligence.com/research-report/single-use-bioprocessing-market

Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiopharmaceuticals Market Size And Industry Forecast By 2030 here

News-ID: 3290990 • Views:

More Releases from DataM Intelligence 4Market Research

United States Peripheral Neuropathy Market Set for Transformative Growth with Rising Treatment Innovations 2025 | Top key players - GlaxoSmithKline, Abbott Laboratories, Cipla Laboratories.
United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth: The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031). The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancements in Treatment & Rising Cardiovascular Cases 2025 | Top key players - Merck, Novartis, Amgen Inc.
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth: The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031. The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and Rising Patient Demand 2025 | Top key players - AdvaCare Pharma, Sanofi, Pfizer Inc.
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth: The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033. The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth with Innovative Therapies Revolutionizing Oncology Care 2025 | Major key players - BioNTech SE, Merck & Co., Inc., Moderna, Inc.
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth: The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033. The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in

All 5 Releases


More Releases for Radiopharmaceutical

Nuclear Medicine Market: Advancing Healthcare with Radiopharmaceutical Innovatio …
The Nuclear Medicine Market is undergoing a rapid transformation in 2025, driven by technological advancements, shifting consumer preferences, and an increased emphasis on sustainability. Companies are leveraging digital solutions, AI-driven analytics, and automation to enhance operational efficiency and improve customer experiences. This report provides an in-depth analysis of key market trends, growth drivers, competitive dynamics, and emerging opportunities. Unlock Insights with a Free Sample Report @ https://www.skyquestt.com/sample-request/nuclear-medicine-market Market Outlook and Growth
Radiopharmaceutical/Nuclear Medicine Market Size and Trends
The radiopharmaceutical/nuclear medicine market is poised for significant expansion in the coming years. With advancements in technology, increasing disease prevalence, and a growing emphasis on personalized medicine, the market presents lucrative opportunities for stakeholders. As the healthcare landscape evolves, the integration of innovative radiopharmaceuticals into clinical practice will continue to enhance diagnostic and therapeutic outcomes, ultimately improving patient care. The key players in the radiopharmaceutical/nuclear medicine market include Eckert & Ziegler,
Radiopharmaceutical Market 2021 | Detailed Report
Radiopharmaceutical Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Radiopharmaceutical Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4123322 The report provides a comprehensive analysis of company profiles listed below: - Bracco Imaging - Bayer - Mallinckrodt - Nordion - Triad Isotopes - Lantheus -
Impressive Trends and Future Scope of Radiopharmaceutical Market
Radiopharmaceutical Market: Introduction According to the report, the global radiopharmaceutical market was valued at US$ 3.6 Bn in 2018 and is projected to expand at a CAGR of ~4% from 2019 to 2027. Some of the factors driving the radiopharmaceutical market are expansion activities of key radiopharma players; applications in clinical trials; and increase in aging population, pipeline assessment of new drugs, and disease indication mortality. Shutdown of some of the
Radiopharmaceutical Market Development Status and Outlook 2024
Radiopharmaceutical Market: Snapshot The global market for radiopharmaceuticals is poised for steady growth in the coming years, driven primarily by the rising use of radioisotopes for the treatment of various diseases, such as cancer, bone palliation, neurological disorders, and cardiovascular diseases. Around 35 million patients undergo treatment procedures for these diseases each year and this will continue to boost the demand for radiopharmaceuticals. Read Report Overview for Radiopharmaceutical Market: http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html According to the
Competition Landscape for Radiopharmaceutical Market Global Industry 2024
The global radiopharmaceutical market was valued at US$4.7 bn in 2015 and is estimated to reach US$7.4 bn by 2024, expanding at a CAGR of 5.3% from 2016 to 2024. Download Exclusive Global Strategic Business Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=213 Radiopharmaceutical Market: Snapshot The global market for radiopharmaceuticals is poised for steady growth in the coming years, driven primarily by the rising use of radioisotopes for the treatment of various diseases, such as cancer, bone palliation, neurological